Genelux prices $10.5M underwritten offering of 3M shares at $3.50/share

GENELUX Corp

Gross proceeds of $10.5M from 3,000,000 shares at $3.50 per share; closing expected March 26, 2025.
Underwriter receives warrant to purchase 120,000 shares at $4.20 per share, exercisable after 180 days.
Proceeds for working capital and continued clinical development of Olvi-Vec.
Titan Partners Group acting as sole bookrunner; offering under effective shelf registration S-3.
Shares sold in registered direct offering; underwriting discounts and expenses not yet disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.